when will oral glp-1 be available The Food and Drug Administration has approved the first weight loss drug by Eli Lilly, called Foundayo The Next GLP-1 Wave: How

Management options may include dose adjustment, temporary treatment interruption, addressing contributing factors (such as optimizing management of gastrointestinal side effects), or considering alternative weight management strategies if symptoms persist and significantly impact quality of life

Serotonin syndrome symptoms may include mental status changes (e.g., agitation, hallucinations, delirium, and coma), autonomic instability (e.g., tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia), neuromuscular symptoms (e.g., tremor, rigidity, myoclonus, hyperreflexia, incoordination), seizures, and/or gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea)

Rate defined the weekly number of discrete events during respective treatment periods

Compared to people not taking any kind of GLP-1, semaglutide (Ozempic) was associated with a 42 percent reduced risk of worsened mental illness